Patients considering renal transplantation face an increasingly complex array of choices as a result of the revised kidney transplant allocation system. Decision aids have been shown to improve patient decision-making through the provision of detailed, relevant, individualized clinical data. A mobile iOS-based application (app) including animated patient education and individualized risk-adjusted outcomes following kidney transplants with varying donor characteristics and DSA waiting times was piloted in two large US transplant programs with a diverse group of renal transplant candidates (N = 81). The majority (86%) of patients felt that the app improved their knowledge and was culturally appropriate for their race/ethnicity (67%-85%).
| INTRODUCTION
The growing complexity of US kidney allocation policy leaves patients with end-stage renal disease (ESRD) with a daunting array of choices when considering transplantation. At the time of initial evaluation, patients are provided with generic education about the risks and benefits of kidney transplantation. Patients who decide to pursue kidney transplantation then need to consider the relative benefits of living donor kidney transplant (LDKT), deceased donor kidney transplant (DDKT) with a low-to-moderate kidney donor profile index (KDPI), DDKT from a high-KPDI (> 85) donor, or a DDKT from a US Public Health Service (PHS) increased infectious risk donor. Patient education generally includes national "expected patient outcomes" without adjustment for individual patient characteristics, nor the wide variation in regional DDKT waitlist time-both of which can influence patients' survival before and after transplant.
As a result of this complexity, potential candidates for transplant report that they do not fully understand their options, leading some to pursue strategies that are not expected to optimize survival. 1 Inadequate education may particularly impact patients with lower socioeconomic status or members of racial/ethnic minorities, contributing to lower rates of referral and transplant listing. [2] [3] [4] [5] [6] In addition, patients may choose to reject high-KDPI and PHS increased-risk organs that are expected to provide benefit out of fear or incomplete understanding of the relative risk of death on dialysis. Nationally, consent rates for nonstandard kidney transplants demonstrate that only half of patients who are expected to benefit from nonstandard DDKT actually consent to receive these organs, 7 contributing to organ discard and reducing access to transplant. 8, 9 The use of decision aids to assist patients in making complex medical decisions has been demonstrated to improve patient empowerment, reduce anxiety, and enhance patient satisfaction. 10, 11 Currently, education programs aimed at increasing interest in transplant do not include individualized, patient-and donor service area (DSA)-specific estimates of transplant benefit with each donor type to assist patients in making informed decisions at the time of listing. [12] [13] [14] [15] My
Transplant Coach (MTC) is a mobile application (app) that provides a self-contained, patient-centered educational program to fully inform patients with ESRD about the impact of these choices on survival. This report describes the content of MTC, its acceptability and culturally competency in a racially and educationally diverse population, and the impact of MTC on patient knowledge, informed decision-making, and interest in kidney transplant in a pilot study.
| METHODS

| Content development
My Transplant Coach was developed by a multidisciplinary team including education professionals, nephrologists, physicians, transplant surgeons, statisticians, and patient representatives. Initial content was developed by the education professionals and validated by the medical nephrology team. Next, the content was reviewed in three focus groups (n = 20 participants) at the University of California, Los Angeles (UCLA), who evaluated data presentation, script content, and overall structure. The data presentation and content were reviewed with the focus groups to assess usability for patients with differing numeracy and literacy skills. Following refinement, an iOS app was developed that includes animated presentation with professional voice-over performances. Currently, the application is only provided in English.
| Description of the application
My Transplant Coach asks patients to enter essential demographic and clinic information and their anticipated transplant center, from which the program generates estimates of survival time for patients with similar characteristics who remain on dialysis, join the DDKT waiting list (including survival associated with willingness to accept nonstandard organs), or receive a LDKT. Patients also receive information on expected post-transplant survival with various levels of KDPI DDKTs and PHS high-risk organs. As these results require explanation, the MTC program includes a series of short video presentations that describe the patient's treatment options, followed by presentation of survival projections in graphical format. The patients are also taught about PHS high-risk donors, the potential for living donor exchange, and the risks of remaining on long-term dialysis.
Information about next steps in pursuing a transplant evaluation, local transplant programs, and the ability to email the results of the analysis are also included in the tool.
| Statistical model development for risk assessment
Analyses in the MTC app were designed to provide projected out- 
| Data presentation
My Transplant Coach includes three analyses for patients. 
| Evaluation design
The MTC application was piloted in two large US transplant programs on the east and west coasts of the U.S.: Ronald Reagan UCLA Medical Center and Massachusetts General Hospital. Patients were recruited at the prior to their initial transplant evaluation and were offered the opportunity to use the application with the assistance of a research assistant. The app pilot and pre-/post-testing was completed prior to standard educational sessions at the transplant program or in the patient's home prior to initial visit. All patients were provided a gift card ($25) for participating in the study. Prior to using the MTC app, participants completed an initial survey (presurvey) to determine demographic data including age, race, ethnicity, whether they were on dialysis, socioeconomic status, educational achievement, health literacy, 17 and previous access to transplant education.
Access to and comfort with technology, including mobile phones and iPads, was assessed by asking whether participants had access to a mobile phone with Internet access or an iPad (yes/no), and whether they were comfortable browsing the Internet or downloading apps on these two technologies (comfortable/not comfortable). Participants also responded to questions regarding knowledge of transplant options and ability to make an informed decision about ESRD treatment options ( Figure 2 ).
Shortly after using the MTC program, participants were surveyed again (postsurvey) about their ability to make an informed decision about ESRD treatment options and their knowledge of transplantation.
They also rated the acceptability and cultural competence of the MTC.
Acceptability was rated with multiple questions on the participants' experience while using the app (eg, "My Transplant Coach helped me to understand the available treatment options," "I could trust the information provided by My Transplant Coach"). Cultural competency was assessed by examining differences in patient reported acceptability across racial groups and levels of access to and comfort with technology, as well as with two specific questions: "My Transplant Coach is suitable for people of my race and ethnic group," and "The graphs were suitable for people with an educational background similar to mine."
On both the pre-and postsurveys, knowledge of transplant was rated by summing the number of correct answers to 20 true/false and multiple choice questions about basic facts, benefits, and risks of transplant to create a scale ranging from 0 to 20. Participants were also asked for general and specific feedback regarding the app.
| Statistical methods
Patient demographics and ratings of the app were summarized using univariate statistics. Differences reported on the postsurvey in rated acceptability and cultural competence from the app by race and comfort using technology were tested with chi-square tests. Change in knowledge levels from the pre-and postsurveys was tested using paired t tests and was made for the total sample, as well as stratified by race/ethnicity, education level, health literacy level, and comfort using technology. Increases in ability to make an informed decision about ESRD treatments (eg, dialysis, deceased or living donor transplant, KDPI or PHS increased-risk deceased donor transplant) from the pre-to postsurvey were rated as the % reporting they would "completely agree" that they have all the facts they need to make an informed decision about each option and were tested with McNemar's tests for the total sample and stratified by race/ethnicity and comfort using technology. Finally, the additional, qualitative comments left on the postsurvey were revised and clustered based on thematic analysis.
| Informed consent
Participants provided written informed consent to participate in the trial prior to beginning the use of the app. The project was reviewed and approved by the Institutional Review Boards at the Ronald Reagan UCLA Medical Center and Massachusetts General Hospital.
| RESULTS
| Participant characteristics
The MTC application was piloted with 81 patients at the two participating transplant centers between February 2015 and May 2016. The average age of the patients surveyed was 52 years, and 49% of the patients were female (Table 1) . Patients came from a broad spectrum of racial and ethnic backgrounds including African Americans (AA) (26%), Hispanics (15%), Asians (25%), and whites (27%). Participants were of modestly higher education than the average population of ESRD patients: 20% of patients had a high school education or less, 55% attended or completed college, and 23% had more than a college degree. More than 50% of the patients had private insurance, and 60% of patients were currently on dialysis. In general, the pilot population was moderately health literate. When asked about assistance with reading hospital materials, 40% of patient reported needing only a little of the time. While most participants had access to a mobile phone with Internet (84%), less than half (48%) had access to an iPad. Sixty percent of participants were comfortable browsing the Internet and downloading apps on a mobile phone, and approximately F I G U R E 2 Brief video explaining the new kidney allocation system half were comfortable browsing the Internet and downloading apps on an iPad (Table 1) .
| Acceptability
The overall impression of the app was very positive, with 86% of users strongly agreeing/agreeing that the MTC app helped them to understand their available treatment options, 83% reported they could trust the information provided by the app, and 85% said they would recommend the app to others (Table 2) . Regarding the graphs specifically, 86% reported that they could understand what the graphs meant, 81% said the graphs contained information relevant to them, and only 17% reported that the graphs were upsetting to them. Finally, 78% and 74%, respectively, said that after using the MTC app, they felt more comfortable speaking to doctors and family/friends about transplant.
| Cultural competence
In general, patients reported that they believe that the content of the app was appropriate for patients of their race/ethnicity (67%-85%) ( Table 2 ). There were no statistically significant differences in ratings of acceptability by race/ethnicity, indicating that the app is culturally competent with regard to race and ethnicity. When queried about their response to the app, 64%-100% of respondents felt that the data display was useful for patients of similar educational achievement.
When stratified by levels of access to and comfort with technology, some differences in ratings of the MTC app's acceptability were observed. Belief that the app was appropriate for them was higher in patients who were comfortable downloading an app on a mobile phone (84% vs. 60%, P = .02), browsing the web on an iPad (88% vs.
61%, P = .001), and downloading an app on an iPad (90% vs. 61%, P = .002). Compared to those who were not comfortable browsing the Internet on a mobile phone, those who were comfortable more frequently reported being comfortable speaking to their doctor (P = .04) and family/friends (P = .02) about transplant after using the MTC app.
Regarding comfort browsing the Internet on an iPad, those who reported being comfortable with this activity more frequently reported the MTC app being acceptable. Technology savvy users were more likely to agree that the graphs added to the information presented in the video (90% vs. 78%, P = .03), they understood what the graphs meant (93% vs. 83%, P = .04), they would watch MTC app again (88% vs. 72%, P = .02). These patients are also comfortable talking about transplant with a doctor (90% vs. 72%, P = .01) or family/friends (85% vs. 69%, P = .04) after using the MTC app.
| Transplant knowledge and informed decisionmaking
Use of the MTC app dramatically increased transplant knowledge in the pilot sample. Median scores on the 20-point test increased by 52% (9.1 to 13.8, P < .001) ( Table 3) . Following the MTC app exposure, the percent of patients able to correctly report that living kidneys last longer than deceased donors increased from 27% to 69% (P < .001) and that the kidney donor profile index predicts graft survival improved from 27% to 80% (P < .001). (Table S1 ). Patients also demonstrated a better understanding of the risks of PHS high-risk kidneys, the improvement in quality of life after transplant, the mechanics of the waiting list, and the purpose of the KPDI score.
Knowledge scores increased among members of all racial and ethnic groups: whites (8.9 to 14.9, P < .001), AAs (9.7 to 11.8, P = .01), Hispanics (8.4 to 13.1, P < .001), and Asians (9.6 to 14.8, P < .001).
The app also appeared to be effective in patients with low educational achievement (6.9 to 11.9, P < .001) and low health literacy (8.0 vs.
13.0, P < .001). Finally, the MTC increased knowledge among patients significantly regardless of whether they reported having access to, or being comfortable with, technology including mobile phones and iPads.
The MTC application also significantly impacted patients' ability to make informed decisions about deceased and living donor kidney transplantation (Tables S2-S5 ). There was a no significant change in patients' understanding of the risks and benefits of dialysis. Prior to viewing the app, only 27% of patients felt that they had all the information needed to make the decision about pursuing DDKT, compared to 52% after viewing the app (P < .001). The proportion of patients who reported sufficient knowledge to make an informed decision about DDKT increased among members of most racial and ethnic groups, levels of educational achievement, and health literacy levels. Among patients who reporting access to or comfort with technology (mobiles phones and iPads), increases in informed decision-making around DDKT were statistically significant, but not for patients reporting no access or comfort with technology. After viewing the app, there was no significant increase in the proportion patients who would "try to get a public health service increased-risk kidney" or "try to get a high-KDPI organ" (P > .05) for both; however, patients were not surveyed about their willingness to accept these organs if offered.
Notably, MTC significantly increased patients' understanding and interest in LDKT, with 72% of patients reporting that they felt fully informed about LDKT after viewing the app, compared with only 40% on the presurvey (P < .001). Among AA patients participating in the pilot, 76% of patients reported feeling fully informed compared with 48% pre-MTC (P = .09) about LDKT. Among whites, the number of patients who felt fully informed about LDKT increased from 18% to 68% after viewing MTC (P < .001). There was a significant benefit for patients across health literacy levels, including those who were least literate (20% to 52%, P = .02). Both patients who reported having access to and comfort with technology, as well as those reporting no access or comfort, had significant increases in informed decision-making about LDKT.
| DISCUSSION
The MTC app resulted in statistically and clinically significant in- (17) 83% (10) 80% (16) 82% (18) 100% (6) 0.81
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67% (14) 83% ( While the MTC app did increase knowledge and motivation in patients to pursue transplant in general, the pilot data failed to demonstrate a beneficial impact of MTC on acceptance of higher risk organs.
This may reflect either the construction of the survey question, which asked if the recipient would "try to get a PHS high-risk donor" or the need to improve the MTC presentation itself. The MTC's failure to encourage acceptance of increased-risk deceased donor kidneys mirrors that of another mobile app-based decision aid, the Inform Me app, which also seeks to increase ESRD patients' knowledge of the risks and benefits of increased-risk deceased donor kidney options. 30 Using a randomized controlled trial design, a recently published evaluation of "Inform Me" found that while it was associated with a 44% higher increased-risk kidney knowledge score than a control group, it was actually associated with a trend toward lower willingness to accept increased-risk kidneys. When patients learn about increased-risk kidneys along with standard criteria deceased donor and living donor kidneys as possible transplant options, without presenting the corresponding risk of death on dialysis, patients rationally question why they would accept increased-risk kidneys. The MTC app provides this context, and the impact on consent rates for high-risk donors will be evaluated in a future trial. Subsequent versions of the app are being developed to improve the presentation of data nonstandard DDKT (high KDPI, PHS high risk) to encourage patients to consent for transplantation with these organs, and success will be determined through better designed assessment tools.
The pilot study demonstrated the need for some technical improvements in the MTC application that are currently being addressed. The application was perceived as too long by some patients. This has been addressed through content and presentation revision. This pilot study was not designed to assess the impact of MTC on patients' actual acceptance of organs of a variety of qualities (eg, high-KDPI organs, PHS increased-risk donor organs). Rather, we focused on knowledge acquisition and cultural acceptance. The data presented in the initial pilot included estimates of the benefits of accepting a high-KPDI or PHS donor kidney and further revision of both presentation and evaluation methods are needed to accurately assess the impact of the MTC app on this decision. A major concern regarding the reported reduction in effectiveness for patients who were less comfortable with, or who had less access to, technology required to use the app, including mobile phones and iPads could be addressed by providing devices within the healthcare environment (eg, dialysis center, transplant center) or training proctors (eg, dialysis technicians) who could assist the user. Future refinement of the MTC will seek to improve the user experience so that it is easy to navigate even for individuals who do not have a high level of proficiency with such technologies. Finally, the models used to predict outcomes are imperfect and will be improved using updated data from the national transplant registry. 27 In the newer versions of the program, DSA-and blood group-specific assessments of waiting time will be assessed for KDPI quartiles and PHS high-risk status.
In conclusion, MTC offers patients with ESRD a comprehensive, culturally acceptable, patient-centered decision aid that improves knowledge of transplant options and empowers patients. After further refinement, a randomized control trial will be launched to evaluate the impact of this tool on access to transplant services including waitlist rates, transplant rates, and early post-transplant outcomes.
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